Gynecology Oncology
Jorge Cea García; Francisco Márquez Maraver; Inmaculada Rodríguez Jiménez; Laura Ríos-Pena; M. Carmen Rubio Rodríguez
Volume 9, Issue 2 , March and April 2024, , Pages 185-200
Abstract
Background & Objective: We aimed to compare sexual function and body image among cervical cancer survivors.Materials & Methods: Between August 1, 2016 and January 31, 2019, we conducted a prospective study with 104 participants. The FSFI and the FACT-Cx v.4.0 (B4 and C7) were the measurement ...
Read More
Background & Objective: We aimed to compare sexual function and body image among cervical cancer survivors.Materials & Methods: Between August 1, 2016 and January 31, 2019, we conducted a prospective study with 104 participants. The FSFI and the FACT-Cx v.4.0 (B4 and C7) were the measurement tools.Results: Forty–seven and twelve hundredths percent reported sexual activity, with the surgical group considerably less sexually active than the non-surgical group (63% vs. 100%, P=0.0003). Throughout the follow-up, we found no significant changes in sexual function (P>0.05). A diagnosis of sexual dysfunction was made in 60.58% of cervical cancer survivors, 80.65% following surgery alone, and in 100% after radiotherapy and chemotherapy. In comparison with survivors who did not receive radiotherapy, irradiated survivors had lower FSFI total scores (1.2 vs. 21.4, P T1=0.0001; 2.1 vs. 21.75, P T2=0.0002). In comparison with the non–chemotherapy group, the chemotherapy group's scores were considerably lower (1.2 vs. 21.15, P T1 <0.0001; 2.4 vs. 18.95, P T2=0.004). We detected no significant changes in body image scores (P=0.184). Except for T1 time assessment (2 vs. 3, P T1=0.016), no differences in body image between the surgical and non-surgical groups were found throughout the follow-up (P T2=0.992; P T3=0.207; P T4=0.139).Conclusion: The rate of female sexual dysfunction was 60.58%, prevailing after therapeutic multimodality, radiotherapy, and chemotherapy. Throughout the follow–up, we discovered no significant changes in sexual activity and function, or in body image. In terms of body image, there were no significant differences between the surgical and non–surgical groups.
Gynecology Oncology
Jorge Cea García; M. Carmen Rubio Rodríguez; Francisco Márquez Maraver; Laura Ríos-Pena; Inmaculada Rodríguez Jiménez
Volume 9, Issue 2 , March and April 2024, , Pages 201-211
Abstract
Background & Objective: Sexual dysfunction is the symptom with the greatest negative impact on the quality of life of cervical cancer survivors. However, the evaluation of sexual function is challenging, and there is ongoing debate concerning its determinants. We aimed to identify predictive ...
Read More
Background & Objective: Sexual dysfunction is the symptom with the greatest negative impact on the quality of life of cervical cancer survivors. However, the evaluation of sexual function is challenging, and there is ongoing debate concerning its determinants. We aimed to identify predictive variables for sexual function after cervical cancer treatment.Materials & Methods: One hundred and four cervical cancer survivors participated in a prospective cohort study that we carried out employing FACT–Cx v.4.0 and FSFI questionnaires.Results: We developed a beta generalized linear model with a predictive accuracy of 78% (C–index=0.78) and based on vaginal shortening (Cx4) (P=0.077), age (P=0.0002), and ovarian preservation (P=0.01) as risk factors, and functional well–being (P<0.0001) and follow–up duration (P=0.015) as protective factors.Conclusion: To the best of our knowledge, we may have created the first reliable and internally validated prediction model for cervical cancer survivors based on predictors like vaginal shortening, age, ovarian preservation, functional well–being, and follow–up duration that significantly affect female sexual function as targets for potential intervention.
